Pregledni rad

APPLICATION OF OMALIZUMAB IN CHRONIC SPONTANEOUS URTICARIA/ANGIOEDEMA: RECOMMENDATIONS, EXPERIENCE AND PERCEPTIONS

LIBORIJA LUGOVIĆ-MIHIĆ orcid.org/0000-0001-7494-5742 ; Klinički bolnički centar Sestre milosrdnice, Klinika za kožne i spolne bolesti, Zagreb i Sveučilište u Zagrebu, Stomatološki fakultet, Zagreb, Hrvatska
IVA FERČEK ; Klinički bolnički centar Sestre milosrdnice, Klinika za kožne i spolne bolesti, Zagreb, Hrvatska
IVA BUKVIĆ ; Klinički bolnički centar Sestre milosrdnice, Klinika za kožne i spolne bolesti, Zagreb i Sveučilište u Zagrebu, Stomatološki fakultet, Zagreb, Hrvatska
TOMISLAV DUVANČIĆ orcid.org/0000-0002-6121-3232 ; Klinički bolnički centar Sestre milosrdnice, Klinika za kožne i spolne bolesti, Zagreb i Sveučilište u Zagrebu, Stomatološki fakultet, Zagreb, Hrvatska

Sažetak

Patients with chronic urticaria (CU), with hives for more than 6 weeks, often experience problems with the unpredictability of hives, social isolation, decreased sleep quality due to associated itchiness and fatigue. In almost half of patients with chronic idiopathic/spontaneous urticaria (CIU/CSU) the cause of the condition was undetermined but 30%-50% of patients were found to produce IgG autoantibodies directed against IgE or its high affinity receptors (Fc

Ključne riječi

chronic urticaria; therapy; omalizumab; chronic idiopathic/spontaneous urticaria

Hrčak ID:

216547

URI

https://hrcak.srce.hr/216547

Datum izdavanja:

30.1.2019.

Podaci na drugim jezicima: hrvatski

Posjeta: 4.145 *